Aktiesnakken — December 2010
-
Hvad sker der med Danisco, efter et flot regnskab så havde jeg ikke regnet med at den skulle falde 2 dage i træk, det er selvfølgelig ikke
-
meget den falder med
-
Thure hvad mener du? Aktien er da stort set flad
-
ahh ok. Jeg troede det var dagens nyhed om at de dropper motavizumab og derfor nedskriver med en lille halv mia dollars
-
Men astrazeneca står lidt i samme situation som Lundbeck. Flere af deres bedst sælgende stoffer er ved at løbe af patent
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind